FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine

The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.